↓ Skip to main content

MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP)

Overview of attention for article published in BMC Medical Imaging, December 2011
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP)
Published in
BMC Medical Imaging, December 2011
DOI 10.1186/1471-2342-11-21
Pubmed ID
Authors

Ali S Arbab, Adarsh Shankar, Nadimpalli RS Varma, Dorrah Deeb, Xiaohua Gao, ASM Iskander, Branislava Janic, Meser M Ali, Subhash C Gautam

Abstract

The current method to determine the efficacy of chemoprevention in TRAMP mouse model of carcinoma of prostate (CaP) is by extracting and weighing the prostate at different time points or by immunohistochemistry analysis. Non-invasive determination of volumes of prostate glands and seminal vesicles before, during and after treatment would be valuable in investigating the efficacy of newer chemopreventive agents in CaP. The purpose of this study was to determine whether in vivo magnetic resonance imaging (MRI) using a 3 tesla clinical MRI system can be used to follow the effect of chemoprevention in TRAMP model of mouse CaP.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 5%
Unknown 19 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 25%
Student > Ph. D. Student 3 15%
Student > Master 2 10%
Student > Doctoral Student 1 5%
Other 1 5%
Other 2 10%
Unknown 6 30%
Readers by discipline Count As %
Medicine and Dentistry 8 40%
Agricultural and Biological Sciences 3 15%
Biochemistry, Genetics and Molecular Biology 2 10%
Computer Science 1 5%
Unknown 6 30%